# Repeated Dose IV Baclofen Safety/Bioequivalence Study

> **NCT02760992** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Allaysis, LLC** · enrollment: 42 (estimated)

## Conditions studied

- Intravenous Baclofen

## Interventions

- **DRUG:** IV Baclofen
- **DRUG:** Oral Baclofen

## Key facts

- **NCT ID:** NCT02760992
- **Lead sponsor:** Allaysis, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05
- **Primary completion:** 2017-09
- **Final completion:** 2017-12
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2016-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02760992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02760992, "Repeated Dose IV Baclofen Safety/Bioequivalence Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02760992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*